AlthausenA.F., ProutG.R., DalyJ.J.: Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116; 575 (1976).
2.
BrosmanS.A.: The use of Bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ. J. Urol., 134; 36 (1985).
3.
De KernionJ.B., KaufmanJ.J.: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J. Urol., 133; 598 (1985).
4.
De KernionJ.B., MaldazysJ.D.: Management of superficial bladder tumors and carcinoma in situ. In: Genitourinary cancer managment.Lea & Febiger Publ., Philadelphia1987.
5.
HeneyN.M.: Superficial bladder cancer: progression and recurrences. J. Urol., 130; 1083 (1983).
6.
HerrH.W.: Carcinoma in situ of the bladder. Semin. Urol., 1; 15 (1983).
7.
MerguerianP.A., DonahuelL., CockettT.K.: Intraluminal Interleukin 2 and Bacillus Calmette-Guérin for treatment of bladder cancer: a preliminary report. J. Urol., 137; 216 (1987).
8.
MoralesA., EdingerD., BruceA.W.: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J. Urol., 116; 180 (1976).
9.
MoralesA.: Long-term results and complications of intracavitary bacillus Calmette-Guérin therapy for bladder cancer. J. Urol., 132; 457 (1984).
10.
RiddleP.R., ChisholmG.D., TrottP.A., PughC.B.: Flat carcinoma in situ of bladder. Brit. J. Urol., 47; 829 (1976).
11.
SolowayM.S., PerryA.: Bacillus Calmette-Guérin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepia and/or mitomycin. J. Urol., 137; 871 (1987).
